John F. Enders Lecture: The Global Introduction of Rotavirus Vaccines: Where Will This Path Lead Us?
Thursday, October 9, 2014: 3:45 PM-4:30 PM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV
At the conclusion of this session, attendees will be able to:
- describe the global burden of Rotavirus disease in the US and in the world
- describe the difference in efficacy of rotavirus vaccines in developed and low and middle income countries
- compare the risks and benefits of rotavirus vaccines introduced in low and middle income countries
- assess the current hurdles to having rotavirus vaccines introduced in low and middle income countries
Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Medical students and residents, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Hospital administrators, HIV specialists, HIV clinicians, Health care workers, Fellows, Epidemiologists, Clinicians, Academicians
Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID
Larry K. Pickering, MD, FIDSA, Centers for Disease Control and Prevention
Maximum of 0.75 hours of AMA PRA Category 1 CreditTM
No CPE credit is offered for this session.
L. K. Pickering,
R. I. Glass,